Your browser doesn't support javascript.
loading
Improving the identification of patients with a genetic diagnosis of familial hypercholesterolaemia in primary care: A strategy to achieve the NHS long term plan.
Ingoe, Lorna; Potter, Aimee; Musson, Susan; Neely, Dermot; Pilkington, Guy; Allen, A Joy; Reay, Danielle; Luvai, Ahai; McAnulty, Ciaron; Camm, Nick; Berry, Ian; Nichols, Jody; Forbes, Gareth; Newton, Julia; Carey, Peter E.
Afiliação
  • Ingoe L; Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, NE1 3BZ, UK; Academic Health Science Network North East and North Cumbria (AHSN), Room 2.13, Biomedical Research Building, The Campus for Ageing and Vitality, Nun's Moor Road, Newcastle, NE4 5PL, UK.
  • Potter A; Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, NE1 3BZ, UK.
  • Musson S; Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, NE1 3BZ, UK.
  • Neely D; Academic Health Science Network North East and North Cumbria (AHSN), Room 2.13, Biomedical Research Building, The Campus for Ageing and Vitality, Nun's Moor Road, Newcastle, NE4 5PL, UK.
  • Pilkington G; Newcastle Gateshead CCG, Riverside House, Goldcrest Way, Newburn Riverside Business Park, Newcastle, NE15 8NY, UK.
  • Allen AJ; Population Health Sciences Institute, The Medical School, Newcastle University, Newcastle, NE2 4HH, UK; NIHR in Vitro Diagnostics Co-operative Newcastle, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
  • Reay D; Northern Genetics Service, The Newcastle Upon Tyne Hospitals NHS Trust, Centre for Life, Central Parkway, Newcastle, NE1 3BZ, UK.
  • Luvai A; Laboratory Medicine, The Newcastle Upon Tyne Hospitals NHS Trust, Newcastle, NE1 3BZ, UK.
  • McAnulty C; Northern Genetics Service, The Newcastle Upon Tyne Hospitals NHS Trust, Centre for Life, Central Parkway, Newcastle, NE1 3BZ, UK.
  • Camm N; Yorkshire and North East Genomic Laboratory Hub, Central Lab. Bexley Wing (Level 5), St. James's University Hospital, Beckett Street, Leed, LS9 7TF, UK.
  • Berry I; Yorkshire and North East Genomic Laboratory Hub, Central Lab. Bexley Wing (Level 5), St. James's University Hospital, Beckett Street, Leed, LS9 7TF, UK.
  • Nichols J; Academic Health Science Network North East and North Cumbria (AHSN), Room 2.13, Biomedical Research Building, The Campus for Ageing and Vitality, Nun's Moor Road, Newcastle, NE4 5PL, UK.
  • Forbes G; Leadgate Surgery, George Ewen House, Watling St, Leadgate, Consett, DH8 6DP, UK.
  • Newton J; Academic Health Science Network North East and North Cumbria (AHSN), Room 2.13, Biomedical Research Building, The Campus for Ageing and Vitality, Nun's Moor Road, Newcastle, NE4 5PL, UK; Population Health Sciences Institute, The Medical School, Newcastle University, Newcastle, NE2 4HH, UK. Electroni
  • Carey PE; South Tyneside and Sunderland NHS Foundation Trust, Kayll Road, Sunderland, Tyne and Wear, SR4 7TP, UK.
Atherosclerosis ; 325: 38-45, 2021 05.
Article em En | MEDLINE | ID: mdl-33892327
ABSTRACT
BACKGROUND AND

AIMS:

We aimed to validate a nurse-led process using electronic health records to identify those at risk of familial hypercholesterolaemia (FH) for genetic diagnosis in primary care.

METHODS:

Those at risk of FH were identified using searches developed and refined locally and implemented in primary care by a trained nurse; they were invited for further assessment and genetic testing if indicated. Family members at risk of FH were identified and invited for cascade testing.

RESULTS:

In total 94,444 patient records were screened (expected prevalence of FH (1 in 250); 377). Of 176 records which already had a diagnostic for FH, 15 had been genetically confirmed and one was undergoing DNA testing. A further 572 (0.61%) were identified as high risk of FH. After desktop screening, 113 (15%) were invited for further assessment. Of these, 73 individuals attended the primary care clinic (64%) of whom 61 (54%) underwent proband genetic testing. Pathogenic variants were detected in 22 cases (36%) and variants of unknown significance in a further 4 cases; a total of 26 probands (43%) were therefore referred for family cascade testing.

CONCLUSIONS:

An optimised FH identification pathway, based on the NICE CG71 recommendations for systematic searching of primary care electronic health records, can be deployed successfully in primary care settings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina Estatal / Hiperlipoproteinemia Tipo II Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina Estatal / Hiperlipoproteinemia Tipo II Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Atherosclerosis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido